What tesamorelin changed in the trials
Tesamorelin Trials: What Happened in the Body
Trials checked organ fat, liver fat, and growth hormones. You'll meet 1 firm limit: nearly everyone studied had HIV.
What did tesamorelin trials find first?
Trials began with people living with HIV. They didn't test routine weight loss. At 2 mg a day, organ fat fell about 15-18%.
This is firm fat deep inside your belly. It isn't the soft layer you can pinch. The result may not fit you without HIV.
Tesamorelin copies a message made by your brain. It reaches the gland below your brain. Growth hormone then leaves that gland.
Growth hormone tells your liver to make IGF-1, another hormone that helps manage stored fat. Neither hormone can promise your result.
FDA approved just one HIV use. It hasn't approved the other uses.
What is tesamorelin built to do?
Tesamorelin has a 44-amino-acid chain, or small protein parts joined together [4]. Its first end was changed to resist being cut apart [6]. It isn't a coating; it's a changed drug part. The altered end keeps the drug whole longer.
You aren't receiving growth hormone itself. Tesamorelin causes your gland to release what it stores. FDA approved one use in 2010.
That use covers HIV patients with extra organ fat [5]. The approval rests on 3 main reports. Together, they followed over 800 patients [1][3][4]. They don't support routine weight loss for you.
The liver-fat trial tells what changed there. The healthy-men study follows your blood hormones. The tesamorelin vs sermorelin page sets the drugs side by side.
What does tesamorelin change in your body?
Tesamorelin reaches the gland below your brain [11]. Growth hormone comes out in brief spurts. Doctors also tracked IGF-1, a hormone made by your liver. Both hormones help your stored fat break down [1].
This was 1 large, late trial. The 26-week study enrolled 412 people with HIV. Each got 2 milligrams a day. It can't show your lifetime result.
Organ fat fell with tesamorelin. It rose after placebo, a shot without drug [1]. Soft belly fat hardly moved. Body weight barely moved too. Triglycerides, one blood fat, fell 50 milligrams per deciliter [1]. Doctors call one-tenth of a liter a deciliter. Without starting levels, that number can't size your change.
In 2026, a review combined 3 types of result. Both organ and liver fat dropped. People kept a little more muscle [15]. The review can't predict your result.
Follow the steps on how tesamorelin works. The organ-fat research page gives each trial's limits.
Who has taken tesamorelin in studies?
The strongest trials reached a narrow group. Researchers enrolled people living with HIV. Each had too much organ fat [5].
That's the only FDA-approved use. The main results come from those patients. You can't assume your body would match.
Another trial checked liver fat in HIV patients [3]. A 12-month study followed adults with obesity. Their bodies made too little growth hormone.
Researchers had them work a leg muscle. A scan timed its stored fuel returning as IGF-1 rose [7]. The test didn't show easier walking or more strength. A small study also watched hormone bursts in healthy men [4].
No large trial proves cosmetic weight loss. Anti-aging and sports uses aren't proven either. Those uses don't have approval.
The frequently asked questions page gives brief answers. Each answer says who was actually studied.
Is tesamorelin a steroid?
Tesamorelin links 44-amino-acid parts, or small protein pieces, into one chain [4]. Steroids and tesamorelin have different builds. Tesamorelin isn't a steroid.
It doesn't act like testosterone. Tesamorelin makes your gland release growth hormone. Your liver then makes IGF-1 [11].
One study tested a different lab message. In older men, testosterone roughly doubled growth hormone released after that message [8]. It doesn't show what tesamorelin would do.
The plain answer for you and your doctor is no. These drugs have different builds. They also do different jobs.
What tesamorelin use has FDA approval?
FDA approval is narrow. It came in November 2010. Only one use has approval.
It treats excess organ fat caused by HIV care [5]. FDA hasn't cleared routine weight loss or anti-aging use.
The main record includes 3 studies. A 26-week study and a 52-week study followed HIV patients [1][2]. A separate trial checked liver fat [3].
A federal liver-safety report found no liver injury clearly caused by tesamorelin [5]. It still can't settle harm over many years.
Athletes can't use the drug under sport rules. That rule doesn't prove safety for you.
Approved medicine and research material aren't alike. The research material belongs in a lab, not your body. The side effects and safety page explains what trials saw.